Literature DB >> 26203195

Nucleolar GTP-binding Protein-1 (NGP-1) Promotes G1 to S Phase Transition by Activating Cyclin-dependent Kinase Inhibitor p21 Cip1/Waf1.

Debduti Datta1, Kumaraswamy Anbarasu1, Suryaraja Rajabather1, Rangasamy Sneha Priya1, Pavitra Desai1, Sundarasamy Mahalingam2.   

Abstract

Nucleolar GTP-binding protein (NGP-1) is overexpressed in various cancers and proliferating cells, but the functional significance remains unknown. In this study, we show that NGP-1 promotes G1 to S phase transition of cells by enhancing CDK inhibitor p21(Cip-1/Waf1) expression through p53. In addition, our results suggest that activation of the cyclin D1-CDK4 complex by NGP-1 via maintaining the stoichiometry between cyclin D1-CDK4 complex and p21 resulted in hyperphosphorylation of retinoblastoma protein at serine 780 (p-RB(Ser-780)) followed by the up-regulation of E2F1 target genes required to promote G1 to S phase transition. Furthermore, our data suggest that ribosomal protein RPL23A interacts with NGP-1 and abolishes NGP-1-induced p53 activity by enhancing Mdm2-mediated p53 polyubiquitination. Finally, reduction of p-RB(Ser-780) levels and E2F1 target gene expression upon ectopic expression of RPL23a resulted in arrest at the G1 phase of the cell cycle. Collectively, this investigation provides evidence that NGP-1 promotes cell cycle progression through the activation of the p53/p21(Cip-1/Waf1) pathway.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  E2F transcription factor; cell cycle; mouse double minute 2 homolog (Mdm2); p53; tumor cell biology

Mesh:

Substances:

Year:  2015        PMID: 26203195      PMCID: PMC4571879          DOI: 10.1074/jbc.M115.637280

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  82 in total

1.  The homologous putative GTPases Grn1p from fission yeast and the human GNL3L are required for growth and play a role in processing of nucleolar pre-rRNA.

Authors:  Xianming Du; Malireddi R K Subba Rao; Xue Qin Chen; Wei Wu; Sundarasamy Mahalingam; David Balasundaram
Journal:  Mol Biol Cell       Date:  2005-10-26       Impact factor: 4.138

2.  Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2.

Authors:  Mu-Shui Dai; Xiao-Xin Sun; Hua Lu
Journal:  Mol Cell Biol       Date:  2008-04-21       Impact factor: 4.272

3.  An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control.

Authors:  A Gualberto; K Aldape; K Kozakiewicz; T D Tlsty
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

Review 4.  Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts.

Authors:  Igor B Roninson
Journal:  Cancer Lett       Date:  2002-05-08       Impact factor: 8.679

5.  Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division.

Authors:  T Evans; E T Rosenthal; J Youngblom; D Distel; T Hunt
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

6.  Gain of function mutations in p53.

Authors:  D Dittmer; S Pati; G Zambetti; S Chu; A K Teresky; M Moore; C Finlay; A J Levine
Journal:  Nat Genet       Date:  1993-05       Impact factor: 38.330

7.  p53 mutations in breast cancer.

Authors:  C Coles; A Condie; U Chetty; C M Steel; H J Evans; J Prosser
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

8.  Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses.

Authors:  Carlos P Rubbi; Jo Milner
Journal:  EMBO J       Date:  2003-11-17       Impact factor: 11.598

9.  Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.

Authors:  C Gillett; V Fantl; R Smith; C Fisher; J Bartek; C Dickson; D Barnes; G Peters
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

10.  Increased expression of mutant forms of p53 oncogene in primary lung cancer.

Authors:  R Iggo; K Gatter; J Bartek; D Lane; A L Harris
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

View more
  11 in total

1.  The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function.

Authors:  Anbarasu Kumaraswamy; Anitha Mamidi; Pavitra Desai; Ananthi Sivagnanam; Lakshmi Revathi Perumalsamy; Chandrasekaran Ramakrishnan; Michael Gromiha; Krishnaraj Rajalingam; Sundarasamy Mahalingam
Journal:  J Biol Chem       Date:  2018-08-23       Impact factor: 5.157

2.  E4BP4/NFIL3 modulates the epigenetically repressed RAS effector RASSF8 function through histone methyltransferases.

Authors:  Isai Pratha Karthik; Pavitra Desai; Sudarkodi Sukumar; Aleksandra Dimitrijevic; Krishnaraj Rajalingam; Sundarasamy Mahalingam
Journal:  J Biol Chem       Date:  2018-02-21       Impact factor: 5.157

3.  A pan-cancer compendium of chromosomal instability.

Authors:  Geoff Macintyre; Florian Markowetz; Ruben M Drews; Barbara Hernando; Maxime Tarabichi; Kerstin Haase; Tom Lesluyes; Philip S Smith; Lena Morrill Gavarró; Dominique-Laurent Couturier; Lydia Liu; Michael Schneider; James D Brenton; Peter Van Loo
Journal:  Nature       Date:  2022-06-15       Impact factor: 69.504

4.  Functional analysis of the 1p34.3 risk locus implicates GNL2 in high-grade serous ovarian cancer.

Authors:  Koji Nakamura; Brett M Reid; Ann Chen; Zhihua Chen; Ellen L Goode; Jennifer B Permuth; Jamie K Teer; Jonathan Tyrer; Xiaoqing Yu; Peter A Kanetsky; Paul D Pharoah; Simon A Gayther; Thomas A Sellers; Kate Lawrenson; Florian A Karreth
Journal:  Am J Hum Genet       Date:  2021-12-28       Impact factor: 11.043

5.  Interplay between human nucleolar GNL1 and RPS20 is critical to modulate cell proliferation.

Authors:  Rehna Krishnan; Neelima Boddapati; Sundarasamy Mahalingam
Journal:  Sci Rep       Date:  2018-07-30       Impact factor: 4.379

6.  Upregulation of GTPBP4 Promotes the Proliferation of Liver Cancer Cells.

Authors:  Jia Chen; Jie Zhang; Zhiwei Zhang
Journal:  J Oncol       Date:  2021-10-19       Impact factor: 4.375

7.  Virus-Host Protein-Protein Interactions between Human Papillomavirus 16 E6 A1 and D2/D3 Sub-Lineages: Variances and Similarities.

Authors:  Guillem Dayer; Mehran L Masoom; Melissa Togtema; Ingeborg Zehbe
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923

8.  Guanine nucleotide binding protein like-1 (GNL1) promotes cancer cell proliferation and survival through AKT/p21 CIP1 signaling cascade.

Authors:  Rehna Krishnan; Mariappan Murugiah; Naga Padma Lakshmi; Sundarasamy Mahalingam
Journal:  Mol Biol Cell       Date:  2020-11-04       Impact factor: 4.138

9.  MIER3 suppresses the progression of non-small cell lung cancer by inhibiting Wnt/β-Catenin pathway and histone acetyltransferase activity.

Authors:  Hongye Zhang; Ling Wang; Juan Bai; Wenyu Jiao; Mingxia Wang
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241

10.  LYAR Promotes Colorectal Cancer Progression by Upregulating FSCN1 Expression and Fatty Acid Metabolism.

Authors:  Yupeng Wu; Yu Zhou; Haiying Gao; Yajun Wang; Qingyu Cheng; Shikun Jian; Qi Ding; Wei Gu; Yanxue Yao; Jia Ma; Wenjuan Wu; Yuyun Li; Xuhui Tong; Xiaoyuan Song; Sai Ma
Journal:  Oxid Med Cell Longev       Date:  2021-12-06       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.